Elisabeth de Vries
机构: Professor of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands
每年引用次数
引用次数
引用: 109,390
H-指数: 142
I10-指数 : 870
出版物: 1,700
Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
Ourania Zoi-Toli , Chris J. L. M. Meijer , Joost J. Oudejans , Els de Vries
The Journal of Pathology 189 ( 4) 533 -538
15
1999
11C-5-HTP and 18F-DOPA PET superior for staging carcinoid and islet cell tumors
Koen Vanghillewe , Adrienne Browers , Wim Sluiter , Klaas Pieter Koopmans
Society of Nuclear Medicine Annual Meeting Abstracts 48
1
2007
One hundred years of the Association of Surgeons in the Netherlands. VIII. Surgical oncology
van der Zee Ag , De Vries Eg , Wiggers T , Pras E
Nederlands Tijdschrift voor Geneeskunde 146 ( 43) 2060
2002
Acute-phase response in patients given rhIL-3 after chemotherapy.
JourikA Gietema , PieterE Postmus , Bonne Biesma , PieterC Limburg
The Lancet 339 ( 8809) 1616 -1617
7
1992
Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.
Nanno Mulder , Jan Zijlstra , de Elisabeth G. E. Vries
Cancer Research 47 ( 7) 1780 -1784
235
1987
Influence of Various Beverages on Urine Acid Output
Nanno Mulder , de Elisabeth G. E. Vries , C Meyer , M Strubbe
Cancer Research 46 ( 1) 430 -432
8
1986
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
M Massobrio , D Katsaros , GL Scheffer , Albert Suurmeijer
Clinical Cancer Research 5 ( 10) 2798 -2805
102
1999
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
P Marmiroli , G Cavaletti , G Tredici , C Meijer
Neurotoxicology 20 ( 6) 883 -887
124
1999
Renal failure after treatment with interferon alpha 2b.
Geesiena Hospers , de Elisabeth G. E. Vries , Wwh Roeloffzen , Gerarda Navis
Anticancer Research 22 ( 3) 1929 -1931
2
2002
Topoisomerase II as a Target of VM-26 and 4′-(9-Acridinylamino)methanesulfon-m-aniside in Atypical Multidrug Resistant Human Small Cell Lung Carcinoma Cells
Nanno Mulder , Jan Zijlstra , de Elisabeth G. E. Vries , de Steven Jong
Cancer Research 53 ( 5) 1064 -1071
21
1993
Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line
Hetty Timmer-Bosscha , Nanno Mulder , Jan Zijlstra , de Elisabeth G. E. Vries
Cancer Research 47 ( 17) 4613 -4617
57
1987
Radiolabeled amino acids : Basic aspects and clinical applications in oncology
Jan Pruim , KJ Langen , W Vaalburg , DA Piers
The Journal of Nuclear Medicine 42 ( 3) 432 -445
496
2001
Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line
Nanno Mulder , Jan Zijlstra , de Elisabeth G. E. Vries , de Steven Jong
Cancer Research 46 ( 6) 2726 -2729
14
1986
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
Nanno Mulder , Jan Zijlstra , de Elisabeth G. E. Vries , de Steven Jong
Cancer Research 50 ( 2) 304 -309
136
1990
18-F-DOPA PET for staging neuroendocrine tumors
K. P. Koopmans , Philippus Elsinga , de Elisabeth G. E. Vries , Willem Sluiter
European Journal of Nuclear Medicine and Molecular Imaging 33
2006
Novel agents in overcoming drug resistance
Hans Nijman , de Elisabeth G. E. Vries , Harmen Hollema , de Steven Jong
European Journal of Cancer 49
2013
Design and synthesis of a fluorine-18 labelled analogue of 5-hydroxy-L-tryptophan for PET imaging of pancreatic neuroendocrine tumours
Adrienne Brouwers , Rudi Dierckx , W. J. Kuik , Philippus Elsinga
European Journal of Nuclear Medicine and Molecular Imaging 38
2011
In vitro uptake studies in a neuroendocrine tumour cell line with PET
K. P. Koopmans , Philippus Elsinga , de Elisabeth G. E. Vries , O. C. Neels
European Journal of Nuclear Medicine and Molecular Imaging 33
2006
PHASE I STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF SARACATINIB (AZD0530) PLUS CARBOPLATIN (C) AND/OR PACLITAXEL (P) IN PATIENTS WITH SOLID TUMOURS
U. Emeribe , M. Prahladan , R. Jones , S. Kaye
Annals of Oncology 21 171 -172
1
2010
Role of Chromogranin A and Neuron-Specific Enolase Biomarkers in Progression-Free Survival (PFS) with Everolimus (EVE) versus Placebo (PB) in Patients with Advanced Pancreatic Neuroendocrine Tumors (pNET) : Phase III RADIANT-3 Results
K. Oberg , R. Winkler , de Elisabeth G. E. Vries , L. Anthony
Neuroendocrinology 94 37 -37
2
2011